Table of Contents

1:  Introduction
        Defining Stem Cell Players and Markets
        CHART: Stem Cell Industry Taxonomy
         - Therapeutics
         - Drug Discovery Tools
         - Stem Cell Banking
  
2:  Stem Cell Approaches
      Background
      Science of Transplantation
      Controlling Immune Rejection and Infection
      Sources and Harvesting of Stem Cells 
        - Embryonic Stem Cells
        - Fetal Stem Cells

        - Adult Stem Cells

        - Stimulation of Endogenous Stem Cells
        - TABLE: Advantages and Disadvantages of Approach by Company
       Scientific Challenges and Advances in Neuro Stem Cell Therapy
       
3:  Trends and Drivers
            CHART: Economic Burden of Stem Cell Related Indications
        Public Policy and Emerging Stem Cell Regions       
            TABLE: Regional distribution of Stem Cell Companies
        Political Trends

            MAP: Global Stem Cell Policy
            CHART: International Funding of Stem Cell Research
        Distribution of Stem Cell Research Centers
        State Funded Initiatives Draw Companies
        Regulatory Trends

           - FDA Approval Process
        Medical Tourism

4: Treatments in Development
       Market Opportunities in Neurology, Psychiatry and Sensory Disorders
         - CHART: Indications for Stem Cell Treatments, Number of People, US and WW
         - TABLE: Treatments in Development by Company and Indication
        Neurodegenerative Diseases
         -  Alzheimer's Disease
         -  Amyotrophic Lateral Sclerosis (ALS)
         -  Huntington's Disease
         -  Parkinson's Disease and Syndrome
       Demyelinating disorders
         -  Multiple sclerosis
       Sensory disorders
         -  Retinal disorders
         -  Hearing loss
        Traumatic injury
         -  Spinal Cord Injury (SCI)
         -  Stroke
       Other CNS diseases

5: Investment Risk and Opportunity
       Private Investment in Stem Cells
          -  TABLE: Business Models in Stem Cells from Low to High Risk
          -  TABLE: Recent Exits in Stem Cells
       Public Market Performance
          -  TABLE: Stem Cell Company Stock Performance and Fundamentals
       Case Studies: What Can Go Wrong?
          -  Case Study 1:  Layton Bioscience Inc.
          -  Case Study 2: BresaGen Ltd.

6:  25 Trendsetters for 2011
       Advanced Cell Technology, Inc.
       ArunA
       Athersys, Inc.
       Beike Biotechnology Company, Ltd.
       BrainCells, Inc.
       BrainStorm Cell Therapeutics, Inc.
       California Stem Cell, Inc.
       Cell Cure Neurosciences, Ltd.
       CellMed
       DaVinci Biosciences
       Geron Corporation
       International Stem Cell Corporation
       iPierian
       Neuralstem, Inc.
       NeuroGeneration, Inc.
       NeuroNova AB
       NsGene A/S
       Pfizer Regenerative Medicine 
       Q Therapeutics
       ReNeuron Group plc
       RhinoCyte, Inc.
       SanBio
       StemCell Technologies, Inc.
       StemCells, Inc.
       Stemedica 
Purchase Now
$2495
Enter email for electronic delivery
and press purchase for next step